The protein level of STING in non-parenchymal liver cells, including macrophages/KCs and endothelial cells, in liver tissues of NAFLD patients is higher than that in non-NAFLD patients (Luo et al., 2018). Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.